Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors.
Grossi
P
P
Pittsburgh Transplantation Institute and Department of Pathology, University of Pittsburgh, Pennsylvania 15213, USA.
Kusne
S
S
Rinaldo
C
C
St George
K
K
Magnone
M
M
Rakela
J
J
Fung
J
J
Starzl
T E
TE
D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D016031:Liver Transplantation; D010750:Phosphoproteins / Q000097:blood*; D014019:Tissue Donors; D014763:Viral Matrix Proteins / Q000097:blood*
D000998:Antiviral Agents; D010750:Phosphoproteins; D014763:Viral Matrix Proteins; C065418:cytomegalovirus matrix protein 65kDa; D015774:Ganciclovir